Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021

BACKGROUND: In partial response to the coronavirus disease 2019 (COVID-19) pandemic, countries around the world are conducting large-scale vaccination campaigns. Real-world estimates of vaccine effectiveness (VE) against the B.1.617.2 (Delta) variant are still limited. An outbreak in Ruili city of C...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Chao, Sun, Weiwei, Tang, Tingting, Jia, Manhong, Liu, Yonghua, Wan, Yongfang, Han, Jizhou, Rodewald, Lance, Li, Junhong, Song, Yudan, Wang, Yamin, Wu, Dan, Wang, Fuzhen, Zheng, Hui, Tang, Lin, Gao, George F., Yin, Zundong, An, Zhijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971107/
https://www.ncbi.nlm.nih.gov/pubmed/35400561
http://dx.doi.org/10.1016/j.vaccine.2022.03.067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971107/
https://www.ncbi.nlm.nih.gov/pubmed/35400561
http://dx.doi.org/10.1016/j.vaccine.2022.03.067

Ejemplares similares